Reglagene
www.reglagene.comNovel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better therapies that improve quality of life and extend life. The Reglagene team is developing a first-in-class blood–brain barrier (BBB) penetrant medicine that effectively fights brain cancer.
Read moreNovel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better therapies that improve quality of life and extend life. The Reglagene team is developing a first-in-class blood–brain barrier (BBB) penetrant medicine that effectively fights brain cancer.
Read moreCountry
State
Arizona
City (Headquarters)
Tucson
Industry
Employees
1-10
Founded
2016
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Pre - Clinical Biology
Email ****** @****.comPhone (***) ****-****Vice President of Discovery
Email ****** @****.comPhone (***) ****-****Board Member | Oncology and Cns | Rare Disease
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(17)